Funding
Chemical ARX degraders

Stefan Kubicek
Breakthrough FY24 Innovative Award (INO)
Duration 2024 - 2025
Targeting mannosylation for regenerating beta cell mass

Stefan Kubicek
Breakthrough T1D Strategic Research Agreement Single Project
Duration 2022 - 2025
CD Laboratory for Chemical Epigenetics and Antiinfectives

Translating Tudor domain splicing inhibitors for oncological applications

Point of Contact: Pinpointing Small Molecule-Protein Binding

Resetting the Epigenetic Status of the DM1Locus

Visual Proteomics for studying subcellular protein dynamics

Innovative chemistry library to probe biology

Mechanistic target elucidation by systematic stochastic tagging of antiproliferative compounds
